GSK Investigational Site

Preston PR2 9HT

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Cough, Refractory Chronic Cough

Studies at this site

• A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough — Running, not enrolling
• A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed